← All indications
Urinary Incontinence, Urge
Involuntary discharge of URINE that is associated with an abrupt and strong desire to void. It is usually related to the involuntary contractions of the detrusor muscle of the bladder (detrusor hyperreflexia or detrusor instability).
Drugs by status
Approved for this indication (9)
Phase 4 trials (7)
Phase 3 trials (6)
Phase 2 trials (1)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (13)
- Astellas
- Pfizer
- Boston Urogynecology Associates
- Brown University
- University of London
- Duke University
- Georgetown University
- Lund University
- University of Kansas
- University of South Florida
- Columbia University
- University of California, San Francisco
- Society of Urodynamics and Female Pelvic Medicine & Urogenital Reconstruction
Organization Involved with Phase 3 Indications (22)
- Alza
- Antares Pharma Inc.
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute on Aging (NIA)
- University of Pennsylvania
- University of Pittsburgh
- Kaiser Permanente
- Loyola University
- Oregon Health and Science University
- RTI International
- Tufts University
- University of New Mexico
- University of Rochester
- University of Zurich
- Mayo Clinic
- University of California, San Diego
- University of North Carolina at Chapel Hill
- University of Alabama, Birmingham
- National Institute of Child Health and Human Development (NICHD)
- The University of Texas, Dallas
- Pelvic Floor Disorders Network
Organization Involved with Phase 2 Indications (7)
Organization Involved with Other Experimental Indications (4)